Skip to content

Examination of single ingestion of drink containing plant extract. A-17004

Examination of single ingestion of drink containing plant extract. A-17004 - Examination of single ingestion of drink containing plant extract. A-17004

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030131
Enrollment
24
Registered
2017-11-27
Start date
2017-11-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

TES Holdings Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Healthy adults 2.Person whose estradiol cycle is stable between 28 and 32 days. 3.Person who is sensitive to cold. 4.Person whose body math indexes are from 18.5 or more to 25 less than 25.0 5.Person whose diastolic blood pressures are less than 90mmHg and systolic ones less than 140mmHg. 6.Person who agrees not to ingest specified foods and supplements during the test period.

Exclusion criteria

Exclusion criteria: 1.Person who has severe allergic disease as rhinitis, atopicdermatitis. 2.Person who is pregnant, lactating or planned to become pregnant during the test period. 3.Patient with vascular function disorder. 4.Person who has problems with electrocardiogram test such as arrhythmia. 5.Person who takes medicine. 6.Person who regularly goes to hospital or went to the medical institution within a month. 7.Current smoker. 8.Person who plans to participate in the other clinical studies. 9.Person who is judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Skin temperature.

Secondary

MeasureTime frame
Peripheral blood flow and subjective evaluation.

Countries

Japan

Contacts

Public ContactShimizu Ryoma

TES Holdings Co., Ltd Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp+81-3-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026